Current Options and Future Directions for NAFLD and NASH Treatment

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, with a broad spectrum ranging from simple steatosis to advanced stage of nonalcoholic steatohepatitis (NASH). Although there are many undergoing clinical trials for NAFLD treatment, there is no currently app...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chunye, Yang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306701/
https://www.ncbi.nlm.nih.gov/pubmed/34299189
http://dx.doi.org/10.3390/ijms22147571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306701/
https://www.ncbi.nlm.nih.gov/pubmed/34299189
http://dx.doi.org/10.3390/ijms22147571

Ejemplares similares